Drug administration in animal studies of cardiac arrest does not reflect human clinical experience
- PMID: 17360097
- PMCID: PMC2039906
- DOI: 10.1016/j.resuscitation.2006.10.032
Drug administration in animal studies of cardiac arrest does not reflect human clinical experience
Abstract
Introduction: To date, there is no evidence showing a benefit from any advanced cardiac life support (ACLS) medication in out-of-hospital cardiac arrest (OOHCA), despite animal data to the contrary. One explanation may be a difference in the time to first drug administration. Our previous work has shown the mean time to first drug administration in clinical trials is 19.4min. We hypothesized that the average time to drug administration in large animal experiments occurs earlier than in OOHCA clinical trials.
Methods: We conducted a literature review between 1990 and 2006 in MEDLINE using the following MeSH headings: swine, dogs, resuscitation, heart arrest, EMS, EMT, ambulance, ventricular fibrillation, drug therapy, epinephrine, vasopressin, amiodarone, lidocaine, magnesium, and sodium bicarbonate. We reviewed the abstracts of 331 studies and 197 full manuscripts. Exclusion criteria included: non-peer reviewed, all without primary animal data, and traumatic models. From these, we identified 119 papers that contained unique information on time to medication administration. The data are reported as mean, ranges, and 95% confidence intervals. Mean time to first drug administration in animal laboratory studies and clinical trials was compared with a t-test. Regression analysis was performed to determine if time to drug predicted ROSC.
Results: Mean time to first drug administration in 2378 animals was 9.5min (range 3.0-28.0; 95% CI around mean 2.78, 16.22). This is less than the time reported in clinical trials (19.4min, p<0.001). Time to drug predicted ROSC (odds ratio 0.844; 95% CI 0.738, 0.966).
Conclusion: Shorter drug delivery time in animal models of cardiac arrest may be one reason for the failure of animal studies to translate successfully into the clinical arena.
Conflict of interest statement
Conflict of Interest Statement
None.
Figures
References
-
- Stiell IG, Wells GA, Field B, Spaite DW, Nesbitt LP, De Maio VJ, Nichol G, Cousineau D, Blackburn J, Munkley D, Lunistra-Toohey L, Campeau T, Dagnone Lyver M. Advanced cardiac life support in out-of-hospital cardiac arrest. N Engl J Med. 2004;351:647–656. - PubMed
-
- Fatovich DM, Prentice DA, Dobb GJ. Magnesium in cardiac arrest (the magic trial) Resuscitation. 1997;35:237–241. - PubMed
-
- Wang HE, Min A, Hostler D, Chang CH, Callaway CW. Differential effects of out-of-hospital interventions on short- and long-term survival after cardiopulmonary arrest. Resuscitation. 2005;67:69–74. - PubMed
-
- Niemann JT, Cairns CB, Sharma J, Lewis RJ. Treatment of prolonged ventricular fibrillation. Immediate countershock versus high-dose epinephrine and CPR preceding countershock. Circulation. 1992;85:281–287. - PubMed
-
- Menegazzi JJ, Davis EA, Yealy DM, Molner RL, Nicklas KA, Hosack GM, Honingford EA, Klain MM. An experimental algorithm versus standard advanced cardiac life support in a swine model of out-of-hospital cardiac arrest. Ann Emerg Med. 1993;22:235–239. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources